SEC61G plays an oncogenic role in hepatocellular carcinoma cells

References

• Bi M, Naczki C, Koritzinsky M, et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. Embo J. 2005;24(19):3470–3481. .
   PubMed Web of Science ®Google Scholar
• Feldman DE, Chauhan V, Koong AC. The unfolded protein response: a novel component of the hypoxic stress response in tumors. Mol Cancer Res. 2005;3:597–605.
   PubMed Web of Science ®Google Scholar
• Koumenis C, Wouters BG. “Translating” tumor hypoxia: unfolded protein response (UPR)-dependent and UPR-independent pathways. Mol Cancer Res. 2006;4:423–436.
   PubMed Web of Science ®Google Scholar
• Senft D, Ronai ZA. UPR, autophagy, and mitochondria crosstalk underlies the ER stress response. Trends Biochem Sci. 2015;40:141–148.
   PubMed Web of Science ®Google Scholar
• Song S, Tan J, Miao Y, et al. Crosstalk of ER stress-mediated autophagy and ER-phagy: involvement of UPR and the core autophagy machinery. J Cell Physiol. 2018;233:3867–3874.
   PubMed Web of Science ®Google Scholar
• Lee AS, Hendershot LM. ER stress and cancer. Cancer Biol Ther. 2006;5:721–722.
   PubMed Web of Science ®Google Scholar
• Urra H, Dufey E, Avril T, et al. Endoplasmic reticulum stress and the hallmarks of cancer. Trends Cancer. 2016;2:252–262.
   PubMed Web of Science ®Google Scholar
• Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell. 2008;13:472–482.
   PubMed Web of Science ®Google Scholar
• Cassim S, Vučetić M, Ždralević M, et al. Warburg and Beyond: the Power of Mitochondrial Metabolism to Collaborate or Replace Fermentative Glycolysis in Cancer. Cancers (Basel). 2020;12(5):1119.
   Web of Science ®Google Scholar
• Cassim S, Raymond V, Lacoste B, et al. Metabolite profiling identifies a signature of tumorigenicity in hepatocellular carcinoma. Oncotarget. 2018;9:26868–26883.
   PubMedGoogle Scholar
• Bernales S, Papa FR, Walter P. Intracellular signaling by the unfolded protein response. Annu Rev Cell Dev Biol. 2006;22:487–508.
   PubMed Web of Science ®Google Scholar
• Schroder M. Endoplasmic reticulum stress responses. Cell Mol Life Sci. 2008;65:862–894.
   PubMed Web of Science ®Google Scholar
• Hetz C, Papa FR. The Unfolded Protein Response and Cell Fate Control. Mol Cell. 2018;69:169–181.
   PubMed Web of Science ®Google Scholar
• Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol. 2007;8:519–529.
   PubMed Web of Science ®Google Scholar
• Ren B, Liu H, Gao H, et al. Celastrol induces apoptosis in hepatocellular carcinoma cells via targeting ER-stress/UPR. Oncotarget. 2017;8:93039–93050.
   PubMedGoogle Scholar
• Linxweiler M, Schick B, Zimmermann R. Let’s talk about Secs: sec61, Sec62 and Sec63 in signal transduction, oncology and personalized medicine. Signal Transduct Target Ther. 2017;2:17002.
   PubMed Web of Science ®Google Scholar
• Zimmermann R, Muller L, Wullich B. Protein transport into the endoplasmic reticulum: mechanisms and pathologies. Trends Mol Med. 2006;12:567–573.
   PubMed Web of Science ®Google Scholar
• Mori Y, Sato F, Selaru FM, et al. Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers. Cancer Res. 2002;62:3641–3645.
   PubMed Web of Science ®Google Scholar
• Schulmann K, Brasch FE, Kunstmann E, et al. HNPCC-associated small bowel cancer: clinical and molecular characteristics. Gastroenterology. 2005;128:590–599.
   PubMed Web of Science ®Google Scholar
• Casper M, Weber SN, Kloor M, et al. Hepatocellular carcinoma as extracolonic manifestation of Lynch syndrome indicates SEC63 as potential target gene in hepatocarcinogenesis. Scand J Gastroenterol. 2013;48:344–351.
   PubMed Web of Science ®Google Scholar
• Lu Z, Zhou L, Killela P, et al. Glioblastoma proto-oncogene SEC61gamma is required for tumor cell survival and response to endoplasmic reticulum stress. Cancer Res. 2009;69:9105–9111.
   PubMed Web of Science ®Google Scholar
• Li WT, Zou AE, Honda CO, et al. Etiology-Specific Analysis of Hepatocellular Carcinoma Transcriptome Reveals Genetic Dysregulation in Pathways Implicated in Immunotherapy Efficacy. Cancers (Basel). 2019;11:1273.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98–W102.
   PubMed Web of Science ®Google Scholar
• Yeo W, Chan SL, Mo FK, et al. Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)-a correlative study to explore potential biomarkers for response. BMC Cancer. 2015;15:395.
   PubMed Web of Science ®Google Scholar
• Azim HA, Peccatori FA, Brohée S, et al. RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy. Breast Cancer Res. 2015;17:24.
   PubMed Web of Science ®Google Scholar
• Wang TL, Diaz LA Jr., Romans K, et al. Q-PCR Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc Natl Acad Sci U S A. 2004;101:3089–3094.
   PubMed Web of Science ®Google Scholar
• Erdogan B, Webb DJ. Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis. Biochem Soc Trans. 2017;45:229–236.
   PubMed Web of Science ®Google Scholar
• Paul CD, Mistriotis P, Konstantopoulos K. Cancer cell motility: lessons from migration in confined spaces. Nat Rev Cancer. 2016;17(2):131–140.
   PubMed Web of Science ®Google Scholar
• Douglas H, Weinberg RA. Hallmarks of Cancer: the Next Generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Benoit L, Valérie-Ann R, Shamir C, et al. Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties. Plos One. 2017;12:e0171215.
   PubMed Web of Science ®Google Scholar
• Brawley OW. Avoidable cancer deaths globally. CA Cancer J Clin. 2011;61:67–68.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Roayaie S, Blume IN, Thung SN, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology. 2009;137:850–855.
   PubMed Web of Science ®Google Scholar
• Goessling W. Deciphering hepatocellular carcinoma: from bench to bedside and back. Gastroenterology. 2009;137:786–788.
   PubMed Web of Science ®Google Scholar
• Dimitroulis D, Damaskos C, Valsami S, et al. From diagnosis to treatment of hepatocellular carcinoma: an epidemic problem for both developed and developing world. World J Gastroenterol. 2017;23:5282–5294.
   PubMed Web of Science ®Google Scholar
• Reis-Filho JS, Pinheiro C, Lambros MB, et al. EGFR amplification and lack of activating mutations in metaplastic breast carcinomas. J Pathol. 2006;209:445–453.
   PubMed Web of Science ®Google Scholar
• Tsukamoto Y, Uchida T, Karnan S, et al. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol. 2008;216:471–482.
   PubMed Web of Science ®Google Scholar
• Liu B, Liu J, Liao Y, et al. Identification of SEC61G as a Novel Prognostic Marker for Predicting Survival and Response to Therapies in Patients with Glioblastoma. Med Sci Monit. 2019;25:3624–3635.
   PubMed Web of Science ®Google Scholar
• Evan G, Vousden K. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411:342–348.
   PubMed Web of Science ®Google Scholar
• Han B. LncRNA LINC02418 regulates proliferation and apoptosis of non-small cell lung cancer cells by regulating miR-4677-3p/SEC61G. Eur Rev Med Pharmacol Sci. 2019;23:10354–10362.
   PubMedGoogle Scholar
• Guo X-Z, Shao X-D, Liu M-P, et al. Effect of bax, bcl-2 and bcl-xL on regulating apoptosis in tissues of normal liver and hepatocellular carcinoma. World J Gastroenterol. 2002;8:1059.
   PubMed Web of Science ®Google Scholar
• Xin M, Li R, Xie M, et al. Small-molecule Bax agonists for cancer therapy. Nat Commun. 2014;5:4935.
   Web of Science ®Google Scholar
• Souers AJ, Leverson JD, Boghaert ER, et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med. 2013;19:202–208.
   PubMed Web of Science ®Google Scholar
• Lakhani SA, Masud A, Kuida K, et al. Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science. 2006;311:847–851.
   PubMed Web of Science ®Google Scholar
• Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell. 2008;14:818–829.
   PubMed Web of Science ®Google Scholar
• Thompson EW, Newgreen DF. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res. 2005;65:5991–5995.
   PubMed Web of Science ®Google Scholar
• Han LL, Jia L, Wu F, et al. Sirtuin6 (SIRT6) promotes the EMT of hepatocellular carcinoma by stimulating autophagic degradation of E-cadherin. Mol Cancer Res. 2019;17:2267–2280.
   PubMed Web of Science ®Google Scholar
• Zhan D, Wei S, Liu C, et al. Reduced N‐cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma. J Gastroenterol Hepatol. 2012;27:173–180.
   PubMed Web of Science ®Google Scholar
• Wang Y, Bu F, Royer C, et al. ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1. Nat Cell Biol. 2014;16:1092–1104.
   PubMed Web of Science ®Google Scholar
• Yuan K, Xie K, Lan T, et al. TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin. Cell Death Differ. 2020;27:1355–1368.
   PubMed Web of Science ®Google Scholar